FindTrial
Sign In

Clinical outcomes of allogeneic hematopoietic stem cell transplantation for acute leukemia

Clinical outcomes of allogeneic hematopoietic stem cell transplantation for acute leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-12002979
Enrollment
Unknown
Registered
2012-12-31
Start date
1998-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute leukemia

Interventions

Group A:sibling donor transplantation
Group B:unrelated donor transplantation

Sponsors

First Affilliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 60 Years

Inclusion criteria

Inclusion criteria: 1. acute leukemia patient according to 2008 WHO criteria; 2. Aged younger than 60 years old; 3. Physical score 0~2(WHO); 4. Sign the informed consent document.

Exclusion criteria

Exclusion criteria: 1. contraindication of hematopoietic stem cell transplantation, e.g. uncontrolled active infection and severe cardiac, hepatic, renal and pulmonary disease; 2. Pregnant; 3. Mental disorder; 4. Physical score>3(WHO); 5. Cann't sign the informed consent document.

Design outcomes

Primary

MeasureTime frame
overall survival;relapse;disease free survival;transplant-related mortality;aGVH;—

Contacts

Public ContactHuang He
hehuangyu@126.com+86 571 87236706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026